tiprankstipranks
Aequus Pharmaceuticals Inc (TSE:AQS)
TSXV:AQS

Aequus Pharmaceuticals (AQS) Financial Statements

14 Followers

Aequus Pharmaceuticals Financial Overview

Aequus Pharmaceuticals's market cap is currently ―. The company's EPS TTM is C$-0.021; its P/E ratio is -1.29; Aequus Pharmaceuticals is scheduled to report earnings on August 26, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total RevenueC$ 52.55KC$ 50.88KC$ 13.36KC$ 98.41KC$ 92.25K
Gross ProfitC$ 34.96KC$ 35.57KC$ 2.90KC$ 51.93KC$ 53.26K
EBITC$ -609.75KC$ -668.23KC$ -767.87KC$ -668.61KC$ -714.83K
EBITDAC$ -576.67KC$ -634.31KC$ -733.12KC$ -633.86KC$ -680.09K
Net Income Common StockholdersC$ -662.09KC$ -715.87KC$ -803.65KC$ -700.88KC$ -744.32K
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 286.89KC$ 215.05KC$ 156.87KC$ 75.24KC$ 89.03K
Total AssetsC$ 1.09MC$ 1.09MC$ 1.17MC$ 885.05KC$ 962.72K
Total DebtC$ 667.16KC$ 693.78KC$ 717.49KC$ 3.34MC$ 2.86M
Net DebtC$ 380.26KC$ 478.73KC$ 560.62KC$ 3.26MC$ 2.77M
Total LiabilitiesC$ 6.04MC$ 5.38MC$ 4.76MC$ 3.68MC$ 3.08M
Stockholders EquityC$ -4.95MC$ -4.29MC$ -3.59MC$ -2.79MC$ -2.12M
Cash Flow-
Free Cash FlowC$ -521.70KC$ -902.11K-C$ -475.15KC$ -266.99K
Operating Cash FlowC$ -521.70KC$ -902.11K-C$ -475.15KC$ -266.99K
Investing Cash Flow-----
Financing Cash FlowC$ 593.55KC$ 960.29K-C$ 461.36KC$ 61.36K
Currency in CAD

Aequus Pharmaceuticals Earnings and Revenue History

Aequus Pharmaceuticals Debt to Assets

Aequus Pharmaceuticals Cash Flow

Aequus Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis